Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Journal for Immunotherapy of Cancer|October 26, 2019
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trialUlka Vaishampayan, Patrick Schöffski, Alain Ravaud, et al.
Cancers|November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancerBernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
BJU International|July 13, 2020
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, et al.
Journal for Immunotherapy of Cancer|July 10, 2020
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohortByoung Chul Cho, Amaury Daste, Alain Ravaud, et al.
Targeted Oncology|August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA CohortMagali Rouyer, Denis Smith, Christophe Laurent, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2020
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumorsMats Någård, Mei-Lin Ah-See, Karen So, et al.
Clinical Colorectal Cancer|January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort StudyAmandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
European Urology|February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 TrialCamillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trialAlain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Journal for Immunotherapy of Cancer|October 26, 2019
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trialUlka Vaishampayan, Patrick Schöffski, Alain Ravaud, et al.
Cancers|November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancerBernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
BJU International|July 13, 2020
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, et al.
Journal for Immunotherapy of Cancer|July 10, 2020
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohortByoung Chul Cho, Amaury Daste, Alain Ravaud, et al.
Targeted Oncology|August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA CohortMagali Rouyer, Denis Smith, Christophe Laurent, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2020
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumorsMats Någård, Mei-Lin Ah-See, Karen So, et al.
Clinical Colorectal Cancer|January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort StudyAmandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
European Urology|February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 TrialCamillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trialAlain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Pageof 23